Overview

  • Product nameLithium chloride
  • Description
    GSK3β inhibitor
  • Biological descriptionDirect, non-competitive GSK3β inhibitor in vitro (Ki = 2 mM). Elicits various neuropharmacological effects.
  • Purity> 99%

Properties

    References for Lithium chloride (ab120853)

    This product has been referenced in:
    • Makoukji J  et al. Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci U S A 109:3973-8 (2012). Read more (PubMed: 22355115) »
    • Pan JQ  et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36:1397-411 (2011). Read more (PubMed: 21389981) »
    • Zhu Q  et al. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo. Prostate 71:835-45 (2011). Read more (PubMed: 21456066) »
    • Klein PS & Melton DA A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93:8455-9 (1996). Read more (PubMed: 8710892) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120853.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"